Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.78 USD | +2.77% | +14.99% | -12.31% |
May. 14 | Sector Update: Health Care Stocks Ease in Tuesday Afternoon Trading | MT |
May. 14 | Pliant Therapeutics Reports Positive Topline Data in Idiopathic Pulmonary Fibrosis Trial | MT |
Financials (USD)
Sales 2024 * | 1.54M | Sales 2025 * | 6.3M | Capitalization | 927M |
---|---|---|---|---|---|
Net income 2024 * | -208M | Net income 2025 * | -245M | EV / Sales 2024 * | 354 x |
Net cash position 2024 * | 380M | Net cash position 2025 * | 393M | EV / Sales 2025 * | 84.8 x |
P/E ratio 2024 * |
-4.5
x | P/E ratio 2025 * |
-4.06
x | Employees | 158 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.59% |
Latest transcript on Pliant Therapeutics, Inc.
1 day | +3.48% | ||
1 week | +14.48% | ||
Current month | +33.76% | ||
1 month | +19.23% | ||
3 months | -4.99% | ||
6 months | +17.11% | ||
Current year | -12.70% |
Managers | Title | Age | Since |
---|---|---|---|
Bernard Coulie
CEO | Chief Executive Officer | 58 | 16-01-31 |
- | - | ||
Keith Cummings
DFI | Director of Finance/CFO | 47 | 18-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 21-01-11 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 16-06-30 |
Gayle Crowell
BRD | Director/Board Member | 73 | 20-01-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 2 M€ | -.--% | ||
0.08% | 0 M€ | 0.00% | - | |
0.07% | 234 M€ | +8.13% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 15.9 | +3.52% | 145 291 |
24-05-15 | 15.36 | +8.63% | 1,269,936 |
24-05-14 | 14.14 | +3.44% | 974,195 |
24-05-13 | 13.67 | -1.01% | 392,358 |
24-05-10 | 13.81 | 0.00% | 487,214 |
Delayed Quote Nasdaq, May 16, 2024 at 12:11 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.70% | 927M | |
+33.17% | 709B | |
+30.77% | 595B | |
-2.15% | 367B | |
+20.27% | 334B | |
+5.33% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+8.96% | 171B |
- Stock Market
- Equities
- PLRX Stock